Journal
NATURE REVIEWS CARDIOLOGY
Volume 8, Issue 4, Pages 207-221Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2011.6
Keywords
-
Categories
Funding
- Medical Research Council [G0802432]
- British Heart Foundation [RG/08/008, FS 05/125, PG/07/133/24,260]
- Department of Health's NIHR Biomedical Research Centers
- MRC [G0802432] Funding Source: UKRI
- British Heart Foundation [FS/11/16/28696] Funding Source: researchfish
- Medical Research Council [G0802432] Funding Source: researchfish
Ask authors/readers for more resources
The prevention of coronary heart disease (CHD) is a major public-health goal, but disease architecture is such that a larger proportion of clinical events occur among the average majority than among the high-risk minority-the prevention paradox. Genetic findings over the past few years have resulted in the reopening of the old debate on whether an individualized or a population-based approach to prevention is preferable. Genetic testing is an attractive tool for CHD risk prediction because it is a low-cost, high-fidelity technology with multiplex capability. Moreover, by contrast with nongenetic markers, genotype is invariant and determined from conception, which eliminates biological variability and makes prediction from early life possible. Mindful of the prevention paradox, this Review examines the potential applications and challenges of using genetic information for predicting CHD, focusing on lipid risk factors and drawing on experience in the evaluation of nongenetic risk factors as screening tests for CHD. Many of the issues we discuss hold true for any late-onset common disease with modifiable risk factors and proven preventative strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available